Skyscape Web Viewer : TNM Cancer Staging Manual : Main Index

View All
Cushing's syndrome
CVC
CVID
CXR
Cyclophosphamide Bone: Appendicular Skeleton, Trunk, Skull and Facial Bones Bone: Pelvis Bone: Spine Leukemia: Acute Myeloid Leukemia Non-Hodgkin Lymphoma: Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma
Cytosine arabinoside
Dasatinib
Deep venous thrombosis (DVT)
Definition of primary tumor (T) for urothelial carcinoma of the prostate
Definition of tumor location for T2a and T2b
Depiction of T4a lesions and the importance of the circumferential margin
Depth of invasion (DOI)
Depth of invasion (DOI) in an ulcerated carcinoma
Depth of invasion of Ta-T2 tumors
DES
Desmoplastic melanoma
Diabetes
Diabetes mellitus, gestational (GDM) Liver prevention guidelines screening for
Diabetes mellitus (DM) type 2\|management of type 2\|oral agents
Diagnostic criteria for multiple myeloma and related plasma cell disorders
Diagram highlighting the location of tumors to be staged as distal bile duct tumors
Differences in defining criteria between the 7th Edition and the 8th Edition for staging of NPC: (A) changing the extent of soft tissue involvement as T2 and T4 criteria
Differences in prognostication of overall survival between the 7th Edition (Left) and the 8th Edition (Right) by (A) T-category, (B) N-category, and (C) stage group for NPC
Differential lymphatic drainage patterns for left and right liver intrahepatic cholangiocarcinomas
Diffuse large B-cell lymphoma COO DLBCL additional factors double-hit and double-expressor DLBCL IPI and related indices Ocular Adnexal Lymphoma prognostic factors, stage grouping
Direct thrombin inhibitors (DTI)
Disease modifying antirheumatic drugs (DMARDs) biologic nonbiologic
Disease progression in gastric GISTs
Disease progression in small intestinal GISTs
Disease-specific survival: all patients, MSKCC data, 8th Edition

NDX